ATE194345T1 - Xanthinderivate - Google Patents

Xanthinderivate

Info

Publication number
ATE194345T1
ATE194345T1 AT92901589T AT92901589T ATE194345T1 AT E194345 T1 ATE194345 T1 AT E194345T1 AT 92901589 T AT92901589 T AT 92901589T AT 92901589 T AT92901589 T AT 92901589T AT E194345 T1 ATE194345 T1 AT E194345T1
Authority
AT
Austria
Prior art keywords
substituted
group
unsubstituted
formula
pct
Prior art date
Application number
AT92901589T
Other languages
English (en)
Inventor
David Glynn Smith
Derek Richard Buckle
Ashley Edward Fenwick
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909027752A external-priority patent/GB9027752D0/en
Priority claimed from GB909027899A external-priority patent/GB9027899D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE194345T1 publication Critical patent/ATE194345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Led Devices (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT92901589T 1990-12-21 1991-12-19 Xanthinderivate ATE194345T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909027752A GB9027752D0 (en) 1990-12-21 1990-12-21 Novel compounds
GB909027899A GB9027899D0 (en) 1990-12-21 1990-12-21 Novel compounds
PCT/GB1991/002286 WO1992011260A1 (en) 1990-12-21 1991-12-19 Xanthine derivatives

Publications (1)

Publication Number Publication Date
ATE194345T1 true ATE194345T1 (de) 2000-07-15

Family

ID=26298155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901589T ATE194345T1 (de) 1990-12-21 1991-12-19 Xanthinderivate

Country Status (14)

Country Link
US (1) US5409934A (de)
EP (1) EP0563168B1 (de)
JP (1) JPH06504534A (de)
KR (1) KR930703319A (de)
AT (1) ATE194345T1 (de)
AU (1) AU649091B2 (de)
CA (1) CA2098846A1 (de)
DE (1) DE69132291T2 (de)
ES (1) ES2148170T3 (de)
IE (1) IE914502A1 (de)
MX (1) MX9102766A (de)
NZ (1) NZ241158A (de)
PT (1) PT99919B (de)
WO (1) WO1992011260A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
EP0825993A1 (de) * 1995-05-19 1998-03-04 Chiroscience Limited Xanthine und ihre therapeutische anwendung
US5981549A (en) * 1997-02-14 1999-11-09 Synapse Pharmaceutical International Method for controlling or alleviating the symptoms of respiratory disease and allergies
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
US6221874B1 (en) * 1998-05-08 2001-04-24 American Home Products Corporation Method of treating bone loss by stimulation of calcitonin
US6133273A (en) * 1998-05-08 2000-10-17 American Home Products Corporation Pyrazolopyrimidine-2,4-dione sulfonamides
JP3914434B2 (ja) * 1999-08-31 2007-05-16 ヴァンダービルト ユニヴァーシティ Ａ２ｂアデノシン受容体の選択的アンタゴニスト
US6821978B2 (en) * 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
JP3998118B2 (ja) * 2000-10-10 2007-10-24 本田技研工業株式会社 電動車両
DE60226615D1 (de) * 2001-08-28 2008-06-26 Schering Corp
WO2003042216A1 (en) * 2001-11-09 2003-05-22 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
US6924140B2 (en) * 2002-06-14 2005-08-02 Lewis J. Daly Closed loop work station bioremediation using mini-reactor cartridges
US7495004B2 (en) * 2002-06-17 2009-02-24 Glaxo Group Limited Purine derivatives as liver X receptor agonists
MXPA06001195A (es) * 2003-07-31 2006-04-11 Schering Corp Metabolito de inhibidor de xantina fosfodiesterasa 5 y derivados del mismo utiles para el tratamiento de la disfuncion erectil.
AR047948A1 (es) * 2003-11-21 2006-03-15 Schering Corp Formulaciuones de inhibidores de la fosfodiesterasa v
WO2006104870A2 (en) * 2005-03-25 2006-10-05 Schering Corporation Methods of treating benign prostatic hyperplasia or lower urinary track symptoms by using pde 5 inhibitors
MX2008015489A (es) 2006-06-06 2009-01-13 Intra Cellular Therapies Inc Compuestos organicos.
ES2588238T3 (es) 2007-12-06 2016-10-31 Intra-Cellular Therapies, Inc. Derivados de pirazolopirimidin-4,6-diona y su uso como producto farmacéutico
US8859564B2 (en) 2008-12-06 2014-10-14 Intra-Cellular Therapies, Inc. Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1
MA32939B1 (fr) 2008-12-06 2012-01-02 Intra Cellular Therapies Inc Composes organiques
AU2009322905A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
JP5879336B2 (ja) 2010-05-31 2016-03-08 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
DE3916469A1 (de) * 1989-05-20 1990-11-22 Basf Ag Sulfonamide
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
IE914502A1 (en) 1992-07-01
KR930703319A (ko) 1993-11-29
DE69132291D1 (en) 2000-08-10
PT99919A (pt) 1992-12-31
PT99919B (pt) 1999-06-30
WO1992011260A1 (en) 1992-07-09
CA2098846A1 (en) 1992-06-22
DE69132291T2 (de) 2000-12-14
EP0563168A1 (de) 1993-10-06
ES2148170T3 (es) 2000-10-16
MX9102766A (es) 1992-09-01
AU649091B2 (en) 1994-05-12
US5409934A (en) 1995-04-25
JPH06504534A (ja) 1994-05-26
AU9122791A (en) 1992-07-22
NZ241158A (en) 1994-12-22
EP0563168B1 (de) 2000-07-05

Similar Documents

Publication Publication Date Title
ATE194345T1 (de) Xanthinderivate
NO901300L (no) Behandling og forbindelser.
HUP0300922A2 (hu) Új vegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0302969A2 (hu) NPY Y5 antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK490288D0 (da) Hidtil ukendte forbindelser
ES8101565A1 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
EP0365364A3 (de) 2-Azetidinonderivate
DK0501892T3 (da) Diazoterede heterocykliske N-substituerede derivater, der indeholder en biphenylmethylgruppe, fremstilling af derivaterne samt lægemidler indeholdende disse
DE69003200D1 (de) Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
DE69206274T2 (de) 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten.
SE8101464L (sv) 2-penem-3-karboxylsyraderivat, deras framstellning och anvendning
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
DK0514442T3 (da) N-Phenyl-N-acetamidoglycinamider, deres fremstilling og lægemidler med indehold deraf
SE9603283D0 (sv) New compounds
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
ATE57930T1 (de) Dihydropyridine.
HUP9900914A2 (hu) Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok
HUP9700954A2 (hu) Szubsztituált 1-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
ES8202003A1 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ATE99326T1 (de) N-phenyl-n-alkoxycarbonylalkyl-glycinamide, ihre herstellung und sie enthaltende medikamente.
DK356287D0 (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
HUP9902041A2 (hu) Új kinoxalin-dion-származékok, a vegyületek előállítása és ezeket tartalmazó gyógyszerkészítmények
KR940014354A (ko) 신규2-페녹시피리미딘유도체,그의제조방법및제초제로서의그의용도

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties